Captopril normalizes insulin signaling and insulin-regulated substrate metabolism in obese (ob/ob) mouse hearts.
about
Obesity, metabolic dysfunction, and cardiac fibrosis: pathophysiological pathways, molecular mechanisms, and therapeutic opportunitiesOverexpression of nuclear receptor SHP in adipose tissues affects diet-induced obesity and adaptive thermogenesisFTO is a relevant factor for the development of the metabolic syndrome in mice.Effect of Treatment of Sprague Dawley Rats with AVE7688, Enalapril, or Candoxatril on Diet-Induced Obesity.Cardiac hypertrophy and fibrosis in the metabolic syndrome: a role for aldosterone and the mineralocorticoid receptorCentral leptin signaling is required to normalize myocardial fatty acid oxidation rates in caloric-restricted ob/ob mice.Early mitochondrial adaptations in skeletal muscle to diet-induced obesity are strain dependent and determine oxidative stress and energy expenditure but not insulin sensitivityUCP3 regulates cardiac efficiency and mitochondrial coupling in high fat-fed mice but not in leptin-deficient mice.Type 2 diabetes, mitochondrial biology and the heart.The effect of angiotensin-converting enzyme inhibition using captopril on energy balance and glucose homeostasis.Examining the role of insulin in the regulation of cardiovascular health.Angiotensin-converting enzyme inhibitors reduce oxidative stress intensity in hyperglicemic conditions in rats independently from bradykinin receptor inhibitors.Effect of captopril and the bradykinin-PKC pathway on ROS production in type 1 diabetic rats.OPA1 deficiency promotes secretion of FGF21 from muscle that prevents obesity and insulin resistance.
P2860
Q26825697-96A057B3-F095-48FE-9637-DFB34D0088F7Q33840297-4E744955-C506-439B-BFD9-FEA49C35040BQ34075518-27AE9403-39E2-4371-9A62-3FDADC7A3184Q34106165-4AAADD8B-FB63-40C1-919A-F4A562D155DCQ35071304-1E735FDB-824B-4ABD-80B6-F6764949B41FQ35796940-E3A5B34D-D0EE-48F8-AC8A-D392AB47E6F0Q35986147-AFE00978-6F39-4192-A15B-2E4A487DAE5EQ36410680-7ED1D22D-B7C0-42F6-A985-02D18BC4CCD3Q37195072-4FF03656-9F0C-4CEB-987A-3B047572137CQ37328877-59D27E82-835A-4286-A3A2-2E744F7A8AF1Q38069198-4B7EF665-F981-4BED-95CB-3A43E79C2521Q41291659-7B42DFCD-77B8-4037-92AF-5D171CFE253CQ45901856-DE8C3D0C-2A61-42B7-8140-15057257A912Q48290464-D60BCB44-B8E8-4E69-88A9-F6FA4058FE8D
P2860
Captopril normalizes insulin signaling and insulin-regulated substrate metabolism in obese (ob/ob) mouse hearts.
description
2008 nî lūn-bûn
@nan
2008 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Captopril normalizes insulin s ...... in obese (ob/ob) mouse hearts.
@en
Captopril normalizes insulin s ...... substrate metabolism in obese
@nl
type
label
Captopril normalizes insulin s ...... in obese (ob/ob) mouse hearts.
@en
Captopril normalizes insulin s ...... substrate metabolism in obese
@nl
prefLabel
Captopril normalizes insulin s ...... in obese (ob/ob) mouse hearts.
@en
Captopril normalizes insulin s ...... substrate metabolism in obese
@nl
P2093
P2860
P356
P1433
P1476
Captopril normalizes insulin s ...... in obese (ob/ob) mouse hearts
@en
P2093
Imene Tabbi-Anneni
Jonathan Buchanan
Robert C Cooksey
P2860
P304
P356
10.1210/EN.2007-1646
P407
P50
P577
2008-05-01T00:00:00Z